Scientists have developed a new approach to enhance T cell therapies for cholangiocarcinoma (CCA), a type of cancer that originates in the bile ducts. The researchers armed T cells,...
The 2nd Thailand Hub of Talents in Cancer Immunotherapy International Conference Cancer Immunotherapy: From Promise to Precision – Delivering Personalized Treatments **Friday 12th July 2024** Faculty of Medicine Siriraj...
https://www.ttci-th.org/wp-content/uploads/2024/06/videoSiCORE31May2024.mp4
https://www.ttci-th.org/wp-content/uploads/2024/06/video1654786515.mp4
https://www.ttci-th.org/wp-content/uploads/2024/06/video1504702293.mp4
Image: www.istockphoto.com A Phase 1 clinical trial to evaluate the safety and early efficacy of CAR T-cell with IL-7Ra signal targeting B7H3 in children with diffuse intrinsic pontine glioma...
Image: www.istockphoto.com Research Topics Development of immunotherapy for lung cancer treatment Researchers Aussara Panya, Yupanun Wutti-in, Sahutchai Inwongwan, Yingmanee Tragoolpua, Thida Kaewkod, Pachara Sattayawat, Chutipa Chiawpanit, Saruda Thongyim, Sitthisak...
CD99, which is highly expressed in T-acute lymphoblastic leukemia (T-ALL), could be an effective target for antibody-based treatment. In this study, researchers used a monoclonal antibody against CD99 called...
Scientists have developed a new and improved chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma, a type of blood cancer. 1 This new therapy uses a third-generation CAR...